versantis.ch valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Home - |
| Description | Committed to transforming prolonging saving revolutionizing the lives of people with liver Who We Are Company Profile The Team Awards and Recognition Our Investors Therapeutic areas About liver disease ACLF UCD CIRRHOSIS HE Pipeline Pipeline VSO |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.2.192.9 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
versantis.ch Valuation
|
US$1,592
Last updated: 2022-07-03 18:26:33
versantis.ch has Semrush global rank of 0. versantis.ch has an estimated worth of US$ 1,592, based on its estimated Ads revenue. versantis.ch receives approximately 183 unique visitors each day. Its web server is located in United States, with IP address 52.2.192.9. According to SiteAdvisor, versantis.ch is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,592 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$44 |
| Yearly Ads Revenue | US$529 |
| Daily Unique Visitors | 12 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| versantis.ch. | A | 3600 | IP: 52.2.192.9 |
| versantis.ch. | NS | 86400 | NS Record: ns.namespace4you.de. |
| versantis.ch. | NS | 86400 | NS Record: ns2.namespace4you.de. |
| versantis.ch. | MX | 3600 | MX Record: 0 versantis-ch.mail.protection.outlook.com. |
| versantis.ch. | TXT | 3600 | TXT Record: MS=ms86848181 |
| versantis.ch. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2022-07-03 18:26:33
| Who We Are Company Profile The Team Awards and Recognition Our Investors Therapeutic areas About liver disease ACLF UCD CIRRHOSIS HE Pipeline Pipeline VSO1 VSO2 TSO1 Scientific Publications News All News Press releases In the Media Events and Presentations Contact Contact Careers Committed to transforming prolonging saving revolutionizing the lives of people with liver diseases Who we are Our Focus Versantis is a global, clinical-stage pharmaceutical company addressing the growing, un-met medical need in liver diseases. We are the first company to demonstrate the potential of scavenging liposomes, a game-changing treatment approach to rapidly conquer multi-organ complications and save lives. Therapeutic areas Click above to see VS-01 in action --> Latest News Apr 13, 2022 Versantis Awarded Innosuisse Grant of CHF475,000 to Develop Point of Care Device to Monitor Blood Ammonia in Liver Disease Patients READ MORE > Mar 21, 2022 Versantis Welcomes Stan Bukofzer, MD, as Scientific |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Thu, 28 Oct 2021 10:07:45 GMT
Content-Type: text/html
Content-Length: 175
X-Hrouter: hrouter3
Location: https://www.versantis.ch/
Age: 0
X-Cache: MISS
X-Cache-Hits: 0
HTTP/2 200
date: Thu, 28 Oct 2021 10:07:45 GMT
content-type: text/html; charset=utf-8
last-modified: Tue, 19 Oct 2021 09:58:49 GMT
cache-control: public, max-age=60
x-hstore: hstore19
x-hrouter: hrouter4
lookup-cache-hit: 1
vary: Accept-Encoding
age: 0
x-cache: MISS
x-cache-hits: 0
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=ZEF49fVA0pp9FovO4%2F2Yo639qQQaikIqXWh3AfJefzRD7jwLwK%2F0Km0wyK5p5OdC9nNCsoSyskgOoH4Yak0E3aasLpCIgAX5JOtRPnXsJcaleBgNr6siF%2Fh8ZqrvObOPLy%2Fl"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
x-content-type-options: nosniff
server: cloudflare
cf-ray: 6a535be6cee52d61-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
|